Henry Louis Salomonsky - Jul 25, 2022 Form 3 Insider Report for Immune Therapeutics, Inc. (IMUN)

Role
Director, 10%+ Owner
Signature
/s/ Henry Louis Salomonsky
Stock symbol
IMUN
Transactions as of
Jul 25, 2022
Transactions value $
$0
Form type
3
Date filed
12/15/2022, 03:46 PM

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding IMUN Common Stock 20 Jul 25, 2022 Direct
holding IMUN Common Stock 12.2M Jul 25, 2022 By trust F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares are owned directly by the H. Louis Salomonsky Jr. Revocable Trust, a ten percent owner of the issuer, and indirectly by Henry Louis Salomonsky as trustee of the trust. Henry Louis Salomonsky is a director and ten percent owner of the issuer.